Generics? Haha , thats a good one Who cares abt the generics What have we met? Even more funny
-ELTP revenue growing Q over Q -ELTP Initiate Pivotal Bioequivalence Study for ELI-201 -ELTP recieve 5mil from Novel stake -ELTP Begin Human Abuse Liability Studies for ELI-200 -ELTP Initiates Pivotal Bioequivalence Study for Third Opioid Abuse Deterrent Product -ELTP Granted New Patent for Abuse Deterrent Technology -ELTP Secures Funding Commitment of Up to $40 Million From Lincoln Park Capital Fund, LLC -ELTP Expands Abuse Deterrent Technology Patent Portfolio Internationally -ELTPReports Successful Pivotal Bioequivalence Study for Abuse Deterrent Product ELI-200 -ELTP Reports positive Results of Pilot Bioequivalence Study for ELI-201 -ELTP Initiates Pivotal Bioequivalence Study for Second Opioid Abuse Deterrent Product